Atlas Trials

A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients

Clinical trial NCT03133247 · COMPLETED

Trial details

NCT number
NCT03133247
Sponsor
Atridia Pty Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2017-06-01
Primary completion
2019-04-09
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.